Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Wallis

Showing results (341-350 of 506) with videos related to

Pageof 51
Sort By:
Clinical Genitourinary Cancer|February 4, 2018
Changing Trends for Suicidal Death in Patients With Bladder Cancer: A 40+ Year Population-level AnalysisZachary Klaassen, Hanan Goldberg, Thenappan Chandrasekar, et al.
Clinical Genitourinary Cancer|April 13, 2020
A Systematic Review and Network Meta-analysis of Novel Androgen Receptor Inhibitors in Non-metastatic Castration-resistant Prostate CancerAmanda E Hird, Diana E Magee, Bimal Bhindi, et al.
European Urology|June 15, 2017
Survival and Complications Following Surgery and Radiation for Localized Prostate Cancer: An International Collaborative ReviewChristopher J D Wallis, Adam Glaser, Jim C Hu, et al.
Prostate Cancer and Prostatic Diseases|July 5, 2022
Development and validation of a multivariable prognostic model in de novo metastatic castrate sensitive prostate cancerSoumyajit Roy, Yilun Sun, Cristopher J D Wallis, et al.
JAMA Network Open|March 4, 2025
Postoperative Outcomes Following Preweekend SurgerySanjana Ranganathan, Carlos Riveros, Yusuke Tsugawa, et al.
European Urology|April 3, 2024
Prostate Radiotherapy in Low-volume Metastatic Hormone-sensitive Prostate Cancer: A Network Meta-analysisSoumyajit Roy, Gagan Fervaha, Daniel E Spratt, et al.
JAMA Network Open|July 1, 2026
First-Line Enfortumab Vedotin Plus Pembrolizumab vs Gemcitabine Plus Cisplatin for Metastatic Urothelial CarcinomaEusebio Luna Velasquez, Renil S Titus, David-Dan Nguyen, et al.
The Lancet. Diabetes & Endocrinology|May 12, 2016
Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort studyChristopher J D Wallis, Kirk Lo, Yuna Lee, et al.
World Journal of Urology|January 2, 2020
Gender-based psychological and physical distress differences in patients diagnosed with non-metastatic renal cell carcinomaRami Ajaj, Jaime Omar Herrera Cáceres, Alejandro Berlin, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 8, 2024
Screening and management of metabolic, cardiac, and bone health in prostate cancer patients on androgen deprivation therapy A survey of specialized physiciansDavid-Dan Nguyen, Ahmad Mousa, Laurence Klotz, et al.
Pageof 51

Showing results (341-350 of 506) with videos related to

Sort By:
Pageof 51
Clinical Genitourinary Cancer|February 4, 2018
Changing Trends for Suicidal Death in Patients With Bladder Cancer: A 40+ Year Population-level AnalysisZachary Klaassen, Hanan Goldberg, Thenappan Chandrasekar, et al.
Clinical Genitourinary Cancer|April 13, 2020
A Systematic Review and Network Meta-analysis of Novel Androgen Receptor Inhibitors in Non-metastatic Castration-resistant Prostate CancerAmanda E Hird, Diana E Magee, Bimal Bhindi, et al.
European Urology|June 15, 2017
Survival and Complications Following Surgery and Radiation for Localized Prostate Cancer: An International Collaborative ReviewChristopher J D Wallis, Adam Glaser, Jim C Hu, et al.
Prostate Cancer and Prostatic Diseases|July 5, 2022
Development and validation of a multivariable prognostic model in de novo metastatic castrate sensitive prostate cancerSoumyajit Roy, Yilun Sun, Cristopher J D Wallis, et al.
JAMA Network Open|March 4, 2025
Postoperative Outcomes Following Preweekend SurgerySanjana Ranganathan, Carlos Riveros, Yusuke Tsugawa, et al.
European Urology|April 3, 2024
Prostate Radiotherapy in Low-volume Metastatic Hormone-sensitive Prostate Cancer: A Network Meta-analysisSoumyajit Roy, Gagan Fervaha, Daniel E Spratt, et al.
JAMA Network Open|July 1, 2026
First-Line Enfortumab Vedotin Plus Pembrolizumab vs Gemcitabine Plus Cisplatin for Metastatic Urothelial CarcinomaEusebio Luna Velasquez, Renil S Titus, David-Dan Nguyen, et al.
The Lancet. Diabetes & Endocrinology|May 12, 2016
Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort studyChristopher J D Wallis, Kirk Lo, Yuna Lee, et al.
World Journal of Urology|January 2, 2020
Gender-based psychological and physical distress differences in patients diagnosed with non-metastatic renal cell carcinomaRami Ajaj, Jaime Omar Herrera Cáceres, Alejandro Berlin, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 8, 2024
Screening and management of metabolic, cardiac, and bone health in prostate cancer patients on androgen deprivation therapy A survey of specialized physiciansDavid-Dan Nguyen, Ahmad Mousa, Laurence Klotz, et al.
Pageof 51